Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CIR’s 161st Expert Panel Meeting: Much Ado About Airbrush Cosmetics; Prostaglandins Make 2023 Priorities

Jun 28 2022

• By Lauren Nardella

Related Content

PCPC ‘Cautiously Optimistic’ About Cosmetics Reform Bill Moving Through Senate

Jun 16 2022

EU's Highest Court Advised Prostaglandin Eyelash Serum Is Not A Medicine Per Se

Jun 17 2022

CIR Expert Panel Announces New Blood Ahead Of 161st Meeting

Jun 16 2022

CIR Panel Throws Up Hands At Airbrush Ingredient Safety, Defers To FDA On Eyelash ‘Enhancers’

Mar 21 2022

US FDA Warning Letter Salvo: No Such Thing As Approved OTC Skin-Lightening Product

Apr 19 2022

Additional Topics

United States Cosmetic Ingredients Safety Cosmetics FDA Consumer

More from Ingredients & Safety

More from HBW Insight

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.